ATE130515T1 - Mittel zur topischen verabreichung von spironolakton. - Google Patents

Mittel zur topischen verabreichung von spironolakton.

Info

Publication number: ATE130515T1
Authority: AT; Austria
Prior art keywords: spironolactone; agent; topical administration; lauramide; activity
Prior art date: 1992-08-06

Application number

AT93306120T

Other languages

English (en)

Inventor

Dario Norberto Ramon D Carrara

Francisco Jose Evarist Stefano

Original Assignee

Beta Pharm Co

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1992-08-06

Filing date

1993-08-03

Publication date

1995-12-15

1993-08-03 Application filed by Beta Pharm Co filed Critical Beta Pharm Co

1995-12-15 Application granted granted Critical

1995-12-15 Publication of ATE130515T1 publication Critical patent/ATE130515T1/de

Links

LXMSZDCAJNLERA-ZHYRCANASA-N spironolactone Chemical compound C([C@@H]1[C@]2(C)CC[C@@H]3[C@@]4(C)CCC(=O)C=C4C[C@H]([C@@H]13)SC(=O)C)C[C@@]21CCC(=O)O1 LXMSZDCAJNLERA-ZHYRCANASA-N 0.000 title abstract 2
229960002256 spironolactone Drugs 0.000 title abstract 2
238000011200 topical administration Methods 0.000 title 1
-1 (C1-C4) alkyl lauramide Chemical compound 0.000 abstract 2
BDYUSDIJIDGWCY-UHFFFAOYSA-N NN-Dimethyllauramide Chemical compound CCCCCCCCCCCC(=O)N(C)C BDYUSDIJIDGWCY-UHFFFAOYSA-N 0.000 abstract 1
230000001548 androgenic effect Effects 0.000 abstract 1
230000000694 effects Effects 0.000 abstract 1
229940116335 lauramide Drugs 0.000 abstract 1
ILRSCQWREDREME-UHFFFAOYSA-N lauric acid amide propyl betaine Natural products CCCCCCCCCCCC(N)=O ILRSCQWREDREME-UHFFFAOYSA-N 0.000 abstract 1
239000003961 penetration enhancing agent Substances 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
- A61K31/585—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin containing lactone rings, e.g. oxandrolone, bufalin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/42—Amides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/63—Steroids; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/008—Preparations for oily skin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q7/00—Preparations for affecting hair growth
- A61Q7/02—Preparations for inhibiting or slowing hair growth

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Epidemiology (AREA)
Dermatology (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Birds (AREA)
Oil, Petroleum & Natural Gas (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Steroid Compounds (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Cosmetics (AREA)

AT93306120T 1992-08-06 1993-08-03 Mittel zur topischen verabreichung von spironolakton. ATE130515T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US92656192A	1992-08-06	1992-08-06

Publications (1)

Publication Number	Publication Date
ATE130515T1 true ATE130515T1 (de)	1995-12-15

Family

ID=25453377

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT93306120T ATE130515T1 (de)	1992-08-06	1993-08-03	Mittel zur topischen verabreichung von spironolakton.

Country Status (6)

Country	Link
EP (1)	EP0582458B1 (de)
AT (1)	ATE130515T1 (de)
DE (1)	DE69300854T2 (de)
DK (1)	DK0582458T3 (de)
ES (1)	ES2083254T3 (de)
MX (1)	MX9303557A (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5599548A (en) *	1995-05-08	1997-02-04	Elizabeth Arden Co., Division Of Conopco, Inc.	Skin care compositions containing fatty acid amides and retinol or retinyl ester
US5693330A (en) *	1996-04-25	1997-12-02	Elizabeth Arden Co., Division Of Conopco, Inc.	Skin care compositions containing melinamide and a retinoid
US5716627A (en) *	1996-04-25	1998-02-10	Elizabeth Arden Co., Division Of Conopco, Inc.	Skin care compositions containing fatty acid amides, azoles, and retinol or retinyl ester
US5955092A (en) *	1996-09-27	1999-09-21	Elizabeth Arden Co., Division Of Conopco, Inc.	Skin care compositions containing an n-substituted fatty acid amide and retinol or retinyl ester
US5747051A (en) *	1996-09-27	1998-05-05	Elizabeth Arden Co., Division Of Conopco, Inc.	Skin care compositions containing an amide of a hydroxy fatty acid and a retinoid
DE19843784A1 (de) *	1998-09-24	2000-04-20	Temic Semiconductor Gmbh	Schaltungsanordnung zur Leistungsverstärkung
AU5460800A (en) *	1999-06-02	2000-12-18	Aviana Biopharm	Pharmaceutical transdermal compositions
US9241944B2 (en) *	2010-06-16	2016-01-26	Institut National De La Santé Et De La Recherche Médicale (Inserm)	Methods and compositions for stimulating reepithelialisation during wound healing
ES2984281T3 (es)	2015-03-03	2024-10-29	Richard W Yee	Composiciones que comprenden un antagonista de la aldosterona para su uso en el tratamiento de ojos secos
US11524016B2 (en)	2020-07-17	2022-12-13	Amy Thorne	Compositions and methods for the topical administration of spironolactone for the treatment of cutaneous signs of excess androgen and chronic stress response

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FI59534C (fi) *	1979-10-31	1981-09-10	Orion Yhtymae Oy	Vaordmedel foer fraemjande av haorvaext och hindrande av mjaell
US4347245A (en) *	1981-05-26	1982-08-31	German Shapiro	Spironolactone-containing composition and use thereof
IT1194185B (it) *	1983-04-01	1988-09-14	Schiapparelli Farma	Composizione per il trattamento dell'acne
FR2588755B3 (fr) *	1985-10-21	1988-01-22	Aron Brunetiere Robert	Composition therapeutique a base de spironolactone destinee au traitement des alopecies androgenogenetiques
AU618517B2 (en) *	1986-12-23	1992-01-02	Eugene J. Van Scott	Additives enhancing topical actions of therapeutic agents
EP0410348A1 (de) *	1989-07-26	1991-01-30	G.D. Searle & Co.	Topische Spironolakton-Zusammensetzung
US5122382A (en) *	1990-10-29	1992-06-16	Alza Corporation	Transdermal contraceptive formulations, methods and devices

1993
- 1993-06-15 MX MX9303557A patent/MX9303557A/es not_active IP Right Cessation
- 1993-08-03 DE DE69300854T patent/DE69300854T2/de not_active Expired - Fee Related
- 1993-08-03 EP EP93306120A patent/EP0582458B1/de not_active Expired - Lifetime
- 1993-08-03 AT AT93306120T patent/ATE130515T1/de not_active IP Right Cessation
- 1993-08-03 DK DK93306120.2T patent/DK0582458T3/da active
- 1993-08-03 ES ES93306120T patent/ES2083254T3/es not_active Expired - Lifetime

Also Published As

Publication number	Publication date
DE69300854T2 (de)	1996-06-05
DK0582458T3 (da)	1996-04-09
ES2083254T3 (es)	1996-04-01
EP0582458B1 (de)	1995-11-22
DE69300854D1 (de)	1996-01-04
MX9303557A (es)	1994-03-31
EP0582458A1 (de)	1994-02-09

Legal Events

Date	Code	Title	Description
1996-05-15	UEP	Publication of translation of european patent specification
1998-05-15	REN	Ceased due to non-payment of the annual fee

Publication	Publication Date	Title
DE69210515D1 (de)	1996-06-13	Kosmetisches Mittel
ATE214933T1 (de)	2002-04-15	Dermatologische zusammensetzungen, welche benzylneroxid und ein mittel zur verminderung von hautreizungen enthalten
ATE332687T1 (de)	2006-08-15	Liponsäure in topischen mittel
GR3006499T3 (de)	1993-06-21
DE69528602D1 (de)	2002-11-21	Prophylaktische behandlung der allergischen kontaktdermatitis
GR3005442T3 (de)	1993-05-24
TW282393B (de)	1996-08-01
HRP930239A2 (en)	1996-06-30	Anti-inflamatory 4-aminophenol derivatives
LV12103A (lv)	1998-08-20	5-alfa-reduktazes inhibitora pielietojums androgenas alopecijas arstesanai
DE69300854D1 (de)	1996-01-04	Mittel zur topischen Verabreichung von Spironolakton.
MX9704775A (es)	1998-02-28	Formulaciones reductoras de irritacion de la piel y su uso.
ATE178201T1 (de)	1999-04-15	Alkoholisches feuchtigkeitsspendendes after shave lotion
FR2687913B1 (de)	1995-06-02
TWI256892B (en)	2006-06-21	Plasminogen activator inhibitor and external preparation for skin comprising the same
PT1123082E (pt)	2006-06-30	Preparacoes para aplicacao topica de substancias de actividade antiandrogenica
GB2347625A (en)	2000-09-13	Agent for treating allergic or hypersensivity condition
EP0678013A1 (de)	1995-10-25	Zusammensetzung zur haarpflege.
IL72620A (en)	1987-10-30	2-hydroxy-benzoyl peroxide and compositions for treating acne
EP0028525A3 (de)	1981-10-28	Behandlungsmittel zur Verbesserung des Haarwuchses und Verhütung von Kopfschuppen
ATE158947T1 (de)	1997-10-15	Hautregenerierende kosmetische zusammensetzung
MX9302419A (es)	1994-03-31	Derivados de acido tetronico, tiotetronico y tetramico.
ES8706027A1 (es)	1987-05-16	Procedimiento de obtencion de una composicion para el tratamiento de vitiligo
DE69600056D1 (de)	1997-10-09	Mittel zur dauerhaften Haarverformung
DE69115745D1 (de)	1996-02-08	Verwendung von Steroidderivaten zur Behandlung der Endometriose
DK131586A (da)	1986-03-21	Transdermalt, antiallergisk, farmaceutisk praeparat